About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Related Articles

Articles

Article icon
Heart Failure Treatment by Device

Published: - Antoni Bayés-Genís,

Citation: European Cardiology Review 2020;15:e17.

Temporary Mechanical Circulatory Support in Acute Heart Failure

Published: - Federica Jiritano, Valeria Lo Coco, Matteo Matteucci,

Citation: Cardiac Failure Review 2020;6:e01.

Left Ventricular Assist Device Support Complicates the Exercise Physiology…

Published: - Erik H Van Iterson,

Citation: Cardiac Failure Review 2019;5(3):162–8.

Choosing between LVAD and BiVAD

Published: - Sajad Shehab, Christopher S Hayward,

Citation: Cardiac Failure Review 2019;5(1):19–23.